Abstract
Advances in endoscopic imaging technology have enabled the detection of gastrointestinal neoplasia at an early stage. This allows for endoscopic treatment to be carried out without the need for radical surgery. As endoscopic treatment increasingly becomes a mainstream treatment option for gastrointestinal cancers, it is important for endoscopists to familiarize themselves with the features of early neoplasia on advanced endoscopic imaging. This chapter provides case illustrations of gastric neoplastic lesions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yao K. The endoscopic diagnosis of early gastric cancer. Ann Gastroenterol. 2013;26(1):11–22.
Ezoe Y, Muto M, Uedo N, Doyama H, Yao K, Oda I, et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology. 2011;141(6):2017–25. e3
Murphy G, Dawsey SM, Engels EA, Ricker W, Parsons R, Etemadi A, et al. Cancer Risk After Pernicious Anemia in the US Elderly Population. Clin Gastroenterol Hepatol. 2015;13(13):2282–9 e1-4.
Yao K, Iwashita A, Tanabe H, Nishimata N, Nagahama T, Maki S, et al. White opaque substance within superficial elevated gastric neoplasia as visualized by magnification endoscopy with narrow-band imaging: a new optical sign for differentiating between adenoma and carcinoma. Gastrointest Endosc. 2008 Sep;68(3):574–80.
Yao K, Iwashita A, Nambu M, Tanabe H, Nagahama T, Maki S, et al. Nature of white opaque substance in gastric epithelial neoplasia as visualized by magnifying endoscopy with narrow-band imaging. Dig Endosc. 2012 Nov;24(6):419–25.
Kanemitsu T, Yao K, Nagahama T, Imamura K, Fujiwara S, Ueki T, et al. Extending magnifying NBI diagnosis of intestinal metaplasia in the stomach: the white opaque substance marker. Endoscopy. 2017 Jun;49(6):529–35.
Shimada H, Fukagawa T, Haga Y, Oba K. Does remnant gastric cancer really differ from primary gastric cancer? A systematic review of the literature by the Task Force of Japanese Gastric Cancer Association. Gastric Cancer. 2016;19(2):339–49.
Horiuchi H, Kaise M, Inomata H, Yoshida Y, Kato M, Toyoizumi H, et al. Magnifying endoscopy combined with narrow band imaging may help to predict neoplasia coexisting with gastric hyperplastic polyps. Scand J Gastroenterol. 2013;48(5):626–32.
Takenaka R, Kawahara Y, Okada H, Tsuzuki T, Yagi S, Kato J, et al. Endoscopic submucosal dissection for cancers of the remnant stomach after distal gastrectomy. Gastrointest Endosc. 2008;67(2):359–63.
Tanaka S, Toyonaga T, Morita Y, Fujita T, Yoshizaki T, Kawara F, et al. Endoscopic submucosal dissection for early gastric cancer in anastomosis site after distal gastrectomy. Gastric Cancer. 2014;17(2):371–6.
Omori T, Kamiya Y, Tahara T, Shibata T, Nakamura M, Yonemura J, et al. Correlation between magnifying narrow band imaging and histopathology in gastric protruding/or polypoid lesions: a pilot feasibility trial. BMC Gastroenterol. 2012;12:17.
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–9.
Kono S, Gotoda T, Yoshida S, Oda I, Kondo H, Gatta L, et al. Can endoscopic atrophy predict histological atrophy? Historical study in United Kingdom and Japan. World J Gastroenterol. 2015;21(46):13113–23.
Kim HG, Thosani N, Banerjee S, Chen A, Friedland S. Effect of prior biopsy sampling, tattoo placement, and snare sampling on endoscopic resection of large nonpedunculated colorectal lesions. Gastrointest Endosc. 2015;81(1):204–13.
Kim JH, Nam HS, Choi CW, Kang DH, Kim HW, Park SB, et al. Risk factors associated with difficult gastric endoscopic submucosal dissection: predicting difficult ESD. Surg Endosc. 2017;31(4):1617–26.
Takeuchi Y, Iishi H, Tanaka S, Saito Y, Ikematsu H, Kudo SE, et al. Factors associated with technical difficulties and adverse events of colorectal endoscopic submucosal dissection: retrospective exploratory factor analysis of a multicenter prospective cohort. Int J Color Dis. 2014;29(10):1275–84.
Coffey RJ, Washington MK, Corless CL, Heinrich MC. Menetrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. J Clin Invest. 2007;117(1):70–80.
Meuwissen SG, Ridwan BU, Hasper HJ, Innemee G. Hypertrophic protein-losing gastropathy. A retrospective analysis of 40 cases in The Netherlands. The Dutch Menetrier Study Group. Scand J Gastroenterol Suppl. 1992;194:1–7.
Rich A, Toro TZ, Tanksley J, Fiske WH, Lind CD, Ayers GD, et al. Distinguishing Menetrier’s disease from its mimics. Gut. 2010;59(12):1617–24.
Setakhr V, Muller G, Hoang P, Lambert AS, Geubel A. Cytomegalovirus-associated protein losing gastropathy in an immunocompetent adult: a case report. Acta Gastro-Enterol Belg. 2007;70(3):296–9.
Drut RM, Gomez MA, Lojo MM, Drut R. Cytomegalovirus-associated Menetrier’s disease in adults. Demonstration by polymerase chain reaction (PCR). Medicina. 1995;55(6):659–64.
Fiske WH, Tanksley J, Nam KT, Goldenring JR, Slebos RJ, Liebler DC, et al. Efficacy of cetuximab in the treatment of Menetrier’s disease. Sci Transl Med. 2009;1(8):8ra18.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Namasivayam, V. (2021). Case Atlas and Illustrations: Upper GI. In: Chiu, P.W.Y., Sano, Y., Uedo, N., Singh, R. (eds) Endoscopy in Early Gastrointestinal Cancers, Volume 1. Springer, Singapore. https://doi.org/10.1007/978-981-10-6769-3_19
Download citation
DOI: https://doi.org/10.1007/978-981-10-6769-3_19
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-6768-6
Online ISBN: 978-981-10-6769-3
eBook Packages: MedicineMedicine (R0)